Compare studies and check their requirements with the research team.
This study is completed in the United States. It focuses on schizophrenia.
In United StatesThis study is completed in the United States. It is testing sublocade for Addiction.
In United States
This study is completed in the United States. It is testing Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss for schizophrenia.
In United StatesThis study is completed in the United States. It is testing pimavanserin for Schizophrenia.
In United StatesThis study is completed in the United States. It is testing aripiprazole Lauroxil for schizophrenia.
In United StatesThis study is enrolling by invitation in the United States. It is testing azetukalner for depression.
In United StatesThis study is enrolling by invitation in the United States, in Finland, and in Poland. It is testing azetukalner for depression.
In United StatesThis study is completed in the United States. It is testing lamictal for OCD.
In United StatesThis study is completed in the United States, in Bulgaria, in Czechia, .... It is testing lumateperone for depression.
In United StatesThis study is enrolling by invitation in the United States, in France, and in Bulgaria. It is testing ML-007C-MA for Schizophrenia.
In United StatesThis study is completed in the United States. It is testing naltrexone for ADHD.
In United StatesThis study is completed in the United States. It is testing NRP104 for ADHD.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.